| Primary |
| Asthma |
66.7% |
| Gastrooesophageal Reflux Disease |
33.3% |
|
| Respiratory Disorder |
100.0% |
|
| Secondary |
| Asthma |
63.5% |
| Drug Use For Unknown Indication |
27.1% |
| Lung Neoplasm Malignant |
4.7% |
| Hypertension |
1.2% |
| Nasal Polyps |
1.2% |
| Pain |
1.2% |
| Rheumatoid Arthritis |
1.2% |
|
| Epidural Lipomatosis |
28.0% |
| Primary Hypogonadism |
16.0% |
| Vomiting |
16.0% |
| Device Misuse |
12.0% |
| Drug Dose Omission |
8.0% |
| Anosmia |
4.0% |
| Dyspnoea |
4.0% |
| Hypersensitivity Vasculitis |
4.0% |
| Scratch |
4.0% |
| Troponin Increased |
4.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.9% |
| Asthma |
27.5% |
| Drug Use For Unknown Indication |
11.6% |
| Hypertension |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Dyspnoea |
2.6% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Bipolar I Disorder |
1.8% |
| Depression |
1.8% |
| Diabetes Mellitus |
1.8% |
| Pain |
1.6% |
| Insomnia |
1.4% |
| Breast Cancer |
1.2% |
| Cardiac Failure |
1.2% |
| Cough |
1.2% |
| Stridor |
1.2% |
| Cardiovascular Event Prophylaxis |
1.0% |
| Hypothyroidism |
1.0% |
| Aspergillus Infection |
0.8% |
|
| Dyspnoea |
11.4% |
| Asthma |
10.0% |
| Oral Mucosa Erosion |
8.6% |
| Drug Ineffective |
5.7% |
| Myocardial Infarction |
5.7% |
| Toxic Skin Eruption |
5.7% |
| Urticaria |
5.7% |
| Cough |
4.3% |
| Depression |
4.3% |
| Renal Disorder |
4.3% |
| Respiratory Disorder |
4.3% |
| Tendon Disorder |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Weight Increased |
4.3% |
| Acute Interstitial Pneumonitis |
2.9% |
| Arthralgia |
2.9% |
| Bronchitis |
2.9% |
| Cholestasis |
2.9% |
| Dizziness |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
|
